Larry Todd Edwards, See Remarks at Arcutis Biotherapeutics, Inc. (ARQT), sold 7,374 shares at $25.16 ($186K) on 2026-03-02, disclosed to the SEC on 2026-03-03.
Open-market sale of $186k ARQT by See Remarks. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $25.16 | 3,584 | $90K | 48.6% |
| 2 | $25.16 | 3,584 | $90K | 48.6% |
| 3 | $25.91 | 103 | $3K | 1.4% |
| 4 | $25.91 | 103 | $3K | 1.4% |
| Total | $25.18 avg | 7,374 | $186K | 100% |
| Filing → |
| ARQT | SELL | 2025-10-06 | $174K | — | Filing → |
| ARQT | SELL | 2025-05-20 | $210K | — | Filing → |
| ARQT | SELL | 2025-02-04 | $28K | — | Filing → |